Mariner
IOVA icon

Mariner’s Iovance Biotherapeutics IOVA Stock Holding History

Mariner’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.1M Buy
505,190
+390,898
+342% +$1.49M ﹤0.01% 1465
2026
Q1 		$401K Buy
+114,292
New +$366K ﹤0.01% 2652
2025
Q4 		– Sell
-22,291
Closed -$48.4K – 3671
2025
Q3 		$48.4K Buy
+22,291
New +$52.6K ﹤0.01% 3451
2025
Q2 		– Sell
-15,922
Closed -$53K – 3574
2025
Q1 		$53K Sell
15,922
-111
-0.7% -$572 ﹤0.01% 3306
2024
Q4 		$119K Sell
16,033
-2,483
-13% -$23K ﹤0.01% 3144
2024
Q3 		$174K Sell
18,516
-866
-4% -$8.21K ﹤0.01% 2968
2024
Q2 		$155K Buy
19,382
+2,722
+16% +$29.2K ﹤0.01% 2851
2024
Q1 		$247K Buy
16,660
+287
+2% +$3.34K ﹤0.01% 2599
2023
Q4 		$133K Sell
16,373
-355,477
-96% -$1.86M ﹤0.01% 2799
2023
Q3 		$1.69M Buy
371,850
+192,450
+107% +$1.26M ﹤0.01% 1049
2023
Q2 		$1.26M Buy
179,400
+72,100
+67% +$516K ﹤0.01% 1173
2023
Q1 		$656K Buy
107,300
+44,600
+71% +$308K ﹤0.01% 1530
2022
Q4 		$401K Buy
+62,700
New +$490K ﹤0.01% 1804

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Mariner's IOVA Position: Q2 2026 in Review

Mariner increased its Iovance Biotherapeutics (IOVA) stake by 342% in Q2 2026, buying an estimated $1.49M and bringing the position to 505,190 shares worth $2.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1465.

Mariner first reported a position in IOVA in Q4 2022 and has held it in 13 quarters since. 293 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Mariner held 505,190 shares of Iovance Biotherapeutics worth $2.1M as of Q2 2026.
  • Mariner bought 390,898 Iovance Biotherapeutics shares in Q2 2026, an estimated $1.49M.
  • Iovance Biotherapeutics made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #1465 holding.
  • Mariner first reported a position in Iovance Biotherapeutics in Q4 2022 and has held it in 13 quarters since.
  • 293 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.